BBZA.DE · BB BIOTECH NAM. SF 0,20
Germany · RS rating 97 · As of 2026-10-14
| Price | 52.20 EUR |
|---|---|
| 1-day change | +56.3% |
| RS rating (overall / 1M / 3M / 12M) | 97 / 99 / 97 / 90 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 62 / 46 / 74 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | +2197.4% |
| Sales growth Q/Q | +2809.1% |
| Distance from 52-week high | +0.0% |
| Market cap (USD) | $3.3B |